Taking the Pulse - A Health Care and Life Sciences Podcast ’s Post

For our final 🏁 post of the week, we cover the last of our founder case studies from our annual MedTech 2024 report. We spoke to Chas Taylor, a serial #entrepreneur and seasoned MedTech device #expert. In this episode, we cover Chas’ experience with Veryan Medical, a company that specialises in creating innovative stents for vascular disease treatment. This highly concentrated and competitive market required careful navigation. With years of experience, Chas gave us clear-set guidance on how to strive for success on the commercialisation journey: 🌎 Kickstart market expansion networks for rapid international growth ⏳ Dive into discussions with regulators and payers early on 🔭 Zoom in on go-to-market and marketing strategy Even though Veryan Medical faced a challenging market during the COVID-19 pandemic, after adjusting accordingly, the company was successfully acquired by Otsuka Medical Devices Co., Ltd. Keep an eye out for our posts next week where we dive into case studies from industry experts 👀 Chas Taylor Esther Reynal de St Michel Richardot Tatum Getty Pamela Walker Saran Davies #vascular #medicaldevice #regulatory #international #medtech

𝐀 𝐛𝐫𝐢𝐠𝐡𝐭 𝐟𝐮𝐭𝐮𝐫𝐞 𝐚𝐭 𝐎𝐜𝐜𝐥𝐮𝐭𝐞𝐜𝐡: 𝐔𝐒 𝐦𝐚𝐫𝐤𝐞𝐭 𝐞𝐧𝐭𝐫𝐲 𝐠𝐫𝐚𝐧𝐭𝐞𝐝 This is a pivotal moment in my journey with Occlutech. We've received FDA approval for our US market entry, a monumental step as we venture into the largest and most dynamic market for medical devices globally. The US market offers unparalleled opportunities for growth and innovation in the medical industry, and we're committed to making a substantial impact. Beyond conquering new territories, our dedication to enhancing global positioning is evident. Currently, the third-largest structural heart occluder company #worldwide, we are ranking second in #Europe – a testament to our team's hard work, dedication, and relentless pursuit of excellence. Our goal is to contribute to healthcare technology advancement, foster innovation across borders, and make a positive impact on lives worldwide. Here's to new beginnings, groundbreaking innovations, and a future where healthcare knows no boundaries! #medtech #MedicalDevices #Innovation #USMarketEntry #GlobalLeadership #Healthcare

How small can a liquid flow sensor get? ...very small. Now in a single-use, cost-efficient package tailored to drug delivery applications.

In an article published in Licensing Journal, MoFo’s Brigid Bondoc, Matt Ferry, Matt Karlyn, and Hannah Koo discuss the recent popularization of at-home diagnostics and #telehealth medicine and the associated risks and costs for companies, and highlight important issues to consider when drafting and negotiating agreements with suppliers and developers around the development, clearance, and commercialization of #athomediagnostics in the United States: https://bit.ly/3L84yBn

Experience the future of diagnostics with Acculab Enlite! Get precise electrolyte results in just 30 seconds. Elevate your lab efficiency today! 🚀🔬 #accurex #AcculabEnlite #precise #electrolyte #LabEfficiency #LabInnovation #ElectrolyteTesting #AccurateResults #Healthcare #medical #MedicalTechnology

What do the lightbulb, the telephone, and the personal computer have in common with Information Mediary Corp’s smart medication adherence solutions? They're all transformative innovations that faced early skepticism but went on to change the world. Just as the lightbulb revolutionized how we illuminate our nights, our Med-ic Smart Blister Package is revolutionizing clinical research. Initially met with doubt, it now ensures precise dosage tracking, real-time data capture, and enhanced patient compliance, ushering in a new era of healthcare. Similar to the telephone, which connected the world, our solutions connect patients and healthcare providers more effectively. Automated reminders and user-friendly interfaces significantly boost adherence rates, making sure patients stay on track with their treatments. In the same way, the personal computer transformed industries and everyday life, our technology streamlines data accuracy and gains regulatory confidence, speeding up the approval process for groundbreaking drugs. These innovations were game-changers, and so are Information Mediary Corp’s smart medication adherence solutions. They ensure that clinical research is more precise, efficient, and patient-friendly — much like how past technologies have redefined their respective fields. Join us in shaping the future of healthcare. Embrace the cutting-edge Med-ic Smart Blister Package and be part of a legacy of innovation that, like the lightbulb, telephone, and PC, will continue to leave a lasting impact. #ClinicalResearch #SmartPackaging #MedTech #Pharma #DrugDevelopment #mems #certiscan www.informationmediary.com Let's illuminate the future of healthcare together!

The global surgical instrument tracking system market is set to generate an estimated revenue of USD 350.9 million in 2024 and is projected to grow at a CAGR of 10.2% from 2024 to 2030, reaching USD 627.4 million by 2030. This significant growth underscores the increasing importance of efficient and accurate tracking systems in healthcare.   𝐌𝐚𝐣𝐨𝐫 𝐒𝐮𝐫𝐠𝐢𝐜𝐚𝐥 𝐈𝐧𝐬𝐭𝐫𝐮𝐦𝐞𝐧𝐭 𝐓𝐫𝐚𝐜𝐤𝐢𝐧𝐠 𝐒𝐲𝐬𝐭𝐞𝐦 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 · BD · B. Braun Group · SpaTrack Medical Limited · STERIS · Stanley Black & Decker, Inc. · Getinge · Scanlan International, Inc. · Censis Technologies, Inc.   𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐦𝐨𝐫𝐞:  https://lnkd.in/gn4DXM2b   #researchreport #medicaltechnology #rfid #barcodetracking #patientsafety #operationalefficiency #Share #surgicalsafety #globalmarket #marketgrowth #techinhealthcare #healthcareindustry #medicalequipment #pnsintelligence

Last week, #Orthocell announced a significant milestone in the Remplir™ US market authorisation study, bringing us closer to potential US approval. With top-line results from the study expected in Q3 CY24, the Company aims to submit an application to the FDA for clearance by the end of the year. Non-executive director, Professor Fiona Wood, said: “Results from the first stage of the study are extremely exciting as it de-risks the pathway to US market clearance and is another positive step towards making this life changing treatment accessible to patients worldwide.” Market entry to the US represents a significant opportunity for Orthocell, with the US peripheral nerve repair market valued at over $1.1 billion annually. We believe that Remplir has the potential to become the market-leading nerve repair device, reducing the need for damaging sutures, and providing an enhanced biological environment to facilitate nerve regeneration and better patient outcomes. Read the announcement 👉 https://lnkd.in/gbU2ddPq $OCC #biotech #regenerativemedicine #medicaldevice #nerverepair #healthcare #innovation

Mainstay Medical, creator of a groundbreaking neurostimulation therapy for lower back pain, received a major vote of confidence as investors put together a $125 million equity financing deal. “A financing of this magnitude will allow us to accelerate our efforts to revolutionize the treatment of mechanical low back pain through ReActiv8 Restorative Neurostimulation, including by continuing our rapid commercial growth and building on our insurance coverage for ReActiv8,” said Jason Hannon, CEO of Mainstay Medical. The financing was co-led by Gilde Healthcare and Viking Global Investors, with the participation from Sofinnova Partners through its Crossover Strategy, Ally Bridge Group, Fountain Healthcare Partners, and PERCEPTIVE LIFE SCIENCES FUND L P. ReActiv8 is an implantable medical device designed to treat adults with intractable chronic low back pain (CLBP) associated with multifidus muscle dysfunction. ReActiv8 has received regulatory approval in several geographic areas, and is commercially available in the European Economic Area, Australia, the UK, and the US. Read more: https://hubs.ly/Q02mlkT_0 Cédric Moreau Claire Catherinet, PhD Medtronic Latham & Watkins Perceptive Advisors Matt Onaitis LifeSci Advisors, LLC Brian Ritchie FTI Consulting Jonathan Neilan #innovation #biotech #chroniclowbackpain #mainstaymedical #SofinnovaPartners #VentureCapital

Revolutionising drug delivery components with precision engineering. Discover how Clamason's expertise is enhancing medical devices to ensure reliable patient care. Learn more: https://bit.ly/3XdBG24 #MedicalDevices #DrugDelivery #PrecisionEngineering #Clamason